A Review on Analytical Challenges in Complex Formulations

Authors

  • Slesha Kumar Kosuru Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • Srinivasa Rao V Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • Suvarna Tadi Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • Jhansi Ch Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • Santhosh Kumar G Department of Pharmaceutical Analysis & Quality Assurance, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.

DOI:

https://doi.org/10.61427/jcpr.v3.i4.2023.111

Keywords:

Formulations, Pharmaceutical Analysis, Stability

Abstract

In the realm of pharmaceutical development and manufacturing, the intricate world of complex drug formulations has garnered significant attention. These multifaceted formulations, often comprising a blend of active pharmaceutical ingredients (APIs) and excipients, present a myriad of analytical challenges. To address these complexities and ensure the safety, efficacy and quality of pharmaceutical products, the industry relies on a combination of advanced analytical techniques, comprehensive knowledge and unwavering commitment to regulatory standards. In the pursuit of solutions to these analytical challenges, the industry is also exploring emerging technologies, including microfluidic devices and mass spectrometry imaging. These innovative tools offer the potential for more detailed and precise analysis of complex formulations. The analytical challenges associated with complex drug formulations demand a multidisciplinary approach, combining traditional and advanced techniques to address the unique characteristics and requirements of each product. Overcoming these challenges is crucial, as it ensures the safety, efficacy and quality of pharmaceutical products, particularly in an industry driven by innovation and the quest to provide cutting-edge therapeutic solutions.

Downloads

Download data is not yet available.

References

Takechi-Haraya Y, Ohgita T, Demizu Y, Saito H, Izutsu KI, Sakai-Kato K. Current Status and Challenges of Analytical Methods for Evaluation of Size and Surface Modification of Nanoparticle-Based Drug Formulations. AAPS Pharm Sci Tech. 2022 May 20; 23(5):150.

Zheng N, Sun DD, Zou P, Jiang W. Scientific and regulatory considerations for generic complex drug products containing nanomaterials. AAPS J. 2017; 19: 619-631.

Choi YH, Han HK. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. J Pharm Investig. 2018; 48: 43-60.

Gagandeep Singh, Dujuan Lu, Chongming Liu, Danny Hower. Analytical challenges and recent advances in the identification and quantitation of extractables and leachables in pharmaceutical and medical products, Trends in Analytical Chemistry, 2021; 141: 116286.

Snehal K Shukla and Vivek Gupta. Analytical challenges and advancements in bioanalysis of therapeutic proteins. Bioanalysis, 2020; 12 (4): 207-9.

Published

2023-10-24
Statistics
86 Views | 76 Downloads
Citatons

How to Cite

Kosuru, S. K. ., S. R. V, S. Tadi, J. Ch, and S. K. G. “A Review on Analytical Challenges in Complex Formulations”. Journal of Clinical and Pharmaceutical Research, vol. 3, no. 4, Oct. 2023, pp. 32-33, doi:10.61427/jcpr.v3.i4.2023.111.

Issue

Section

Review Articles

Most read articles by the same author(s)